Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant to Prevent Delirium After Heart Surgery
NCT06630390Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative delirium (POD) comparing Daridorexant with Placebo (2 arms). Primary endpoint: Delirium Incidence at 3 days. Started Nov 2024; status: completed.
02
Drugs
daridorexant
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06630390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06630390.